Xuejun Zhang

No. 666 High Tech Avenue, East Lake High Tech Development Zone
Wuhan, 430075, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Discovery and Preclinical Evaluations of Potent, Selective, and Allosteric Covalent WRN Inhibitors with Improved PK Properties.

Discovery and Preclinical Evaluations of Potent, Selective, and Allosteric Covalent WRN Inhibitors with Improved PK Properties.

Journal: ACS medicinal chemistry letters

Published: December 31, 2025

Development of a P2X3 receptor antagonist derived from eliapixant with improved properties for the treatment of chronic cough.

Development of a P2X3 receptor antagonist derived from eliapixant with improved properties for the treatment of chronic cough.

Journal: European journal of medicinal chemistry

Published: July 17, 2025

Discovery of HW201877: A Highly Potent and Orally Bioavailable Inhibitor of 15-Prostaglandin Dehydrogenase to Potentiate Tissue Repair and Regeneration.

Discovery of HW201877: A Highly Potent and Orally Bioavailable Inhibitor of 15-Prostaglandin Dehydrogenase to Potentiate Tissue Repair and Regeneration.

Journal: Journal of medicinal chemistry

Published: June 26, 2025

Discovery and evaluation of HW161023 as a potent and orally active AAK1 inhibitor.

Discovery and evaluation of HW161023 as a potent and orally active AAK1 inhibitor.

Journal: Bioorganic & medicinal chemistry letters

Published: March 02, 2024

Multifunctional Bi2S3-Au nanoclusters for fluorescence/infrared thermal imaging guided photothermal therapy.

Multifunctional Bi2S3-Au nanoclusters for fluorescence/infrared thermal imaging guided photothermal therapy.

Journal: International journal of pharmaceutics: X

Published: January 30, 2024

Analysis of poor prognostic factors for septic arthritis of the hip in children: a case series of 76 patients.

Analysis of poor prognostic factors for septic arthritis of the hip in children: a case series of 76 patients.

Journal: Journal of pediatric orthopedics. Part B

Published: December 04, 2023

Discovery of Potent and Oral Bioavailable MAT2A Inhibitors for the Treatment of MTAP-Deleted Tumors.

Discovery of Potent and Oral Bioavailable MAT2A Inhibitors for the Treatment of MTAP-Deleted Tumors.

Journal: ACS medicinal chemistry letters

Published: October 26, 2023

Discovery and Evaluation of Pyrazolo[3,4-d]pyridazinone as a Potent and Orally Active Irreversible BTK Inhibitor.

Discovery and Evaluation of Pyrazolo[3,4-d]pyridazinone as a Potent and Orally Active Irreversible BTK Inhibitor.

Journal: ACS medicinal chemistry letters

Published: August 23, 2019

Showing 1-8 of 8

Last Updated: 09/26/2026